Introducing way more signals! We've added more signal sources to capture the full customer journey.

Learn More!

TreeFrog Therapeutics

TreeFrog Therapeutics provides access to cell therapies for patients. The company has developed C-StemTM, a high-throughput cell encapsulation technology allowing for the mass-production and differentiation of stem cells in industrial bioreactors. This proprietary technology platform provides an end-to-end and scalable solution that dramatically improves the quality of therapeutic cells and reduce production costs. The company was founded in 2018 and is headquartered in France.

Last updated on

About TreeFrog Therapeutics

Founded

2018

Estimated Revenue

$1M-$10M

Employees

11-50

Funding / Mkt. Cap

$87M

Category

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Location

City

Pessac

State

Nouvelle-Aquitaine

Country

France

TreeFrog Therapeutics

Find your buyer within TreeFrog Therapeutics

Tech Stack (83)

search